Boiron (XPAR:BOI) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:BOI Boiron SA XPAR:BOI
78 GF Score
Price €27.50
GF Value €34.11
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Boiron Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

XPAR:BOI
78GF Score
Boiron SA XPAR:BOI
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Boiron (XPAR:BOI) Overvalued in 2026?

Based on GuruFocus' analysis, Boiron stock appears to be undervalued. The current stock price of €27.50 is trading 19.4% below its estimated GF Value™ of €34.11. GuruFocus considers Boiron to be Modestly Undervalued.

Key valuation signals for XPAR:BOI:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €34.11 vs. price of €27.50 (19.4% below fair value)
  • GF Score™: 78/100 with 4 warning signs

No single metric tells the full story. See the XPAR:BOI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Boiron Business Description

Other Exchanges BOIRF:USA0DTF:UKBON:Germany
Address 2, Avenue de l’Ouest Lyonnais No. 039, Messimy, FRA, 69510
Boiron SA is a drug manufacturer that focuses on homeopathic products. The company's revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boiron's nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The company's products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.
78GF Score

Get the complete analysis for XPAR:BOI

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€27.50
Price
€34.11
GF Value